Welcome to Medical Centre Pharmacy, your hometown pharmacy!

Human Papillomavirus: HPV

At Medical Centre Pharmacy is dedicated to bringing you the most up to date information and immunizations

Human Papillomavirus: HPV

November 6, 2013
|
Comments off
|

HPV is a DNA virus from the papillomavirus family that is capable of infecting humans.

Like all papillomaviruses, HPVs establish productive infections only in keratinocytes of the skin or mucous membranes. While the majority of the known types of HPV cause no symptoms in most people, some types can cause warts (verrucae), while others can—in a minority of cases—lead to cancers of the cervix, vulva, vagina, penis, oropharynx, and anus. Recently, HPV has been linked with an increased risk of cardiovascular disease. In addition, HPV 16 and 18 infections are strongly associated with an increased odds ratio of developing oropharyngeal (throat) cancer.

More than 30 to 40 types of HPV are typically transmitted through sexual contact and infect the anogenital region. Some sexually transmitted HPV types may cause genital warts. Persistent infection with “high-risk” HPV types – different from the ones that cause skin warts – may progress to precancerous lesions and invasive cancer. HPV infection is a cause of nearly all cases of cervical cancer. However, most infections do not cause disease.

Most HPV infections in young women are temporary and have little long-term significance. Seventy percent of infections are gone in 1 year and ninety percent in 2 years. However, when the infection persists, in 5% to 10% of infected women, there is high risk of developing precancerous lesions of the cervix. This can progress to invasive cervical cancer. This process usually takes 10 – 15 years, providing many opportunities for detection and treatment of the precancerous lesion. Progression to invasive cancer can be almost always prevented when standard prevention strategies are applied, but the lesions still cause considerable burden necessitating preventive surgeries, which do in many cases involve loss of fertility.

Managing the virus

In more developed countries, cervical screening using a Papanicolaou (Pap) test or liquid-based cytology is used to detect abnormal cells that may develop into cancer. If abnormal cells are found, women are invited to have a colposcopy. During a colposcopic inspection, biopsies can be taken and abnormal areas can be removed with a simple procedure, typically with a cauterizing loop or more commonly by freezing (cryotherapy). Treating abnormal cells in this way can prevent them from developing into cervical cancer.

Pap smears have reduced the incidence and fatalities of cervical cancer in the developed world, but even so there were 11,000 cases and 3,900 deaths in the U.S. in 2008. Cervical cancer has substantial mortality in resource–poor areas. Worldwide, there are an estimated 490,000 cases and 270,000 deaths each year.

HPV vaccines (Cervarix and Gardasil), which prevent infection with the HPV (types 16 and 18) that cause 70% of cervical cancer, may lead to further decreases.

Comments are closed.